Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Persistent perceptions of vulnerability following neonatal jaundice.

K J Kemper1, B W Forsyth, P L McCarthy

  • 1Department of Pediatrics, University of Washington, Harborview Medical Center, Seattle 98104.

American Journal of Diseases of Children (1960)
|February 1, 1990
PubMed
Summary

Treatments for neonatal jaundice may increase risks for vulnerable child syndrome. Infants with jaundice experienced more feeding issues and mothers perceived health problems as more serious, warranting careful consideration of treatment benefits versus risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study.

Bone marrow transplantation·2016
Same author

Consolidation and maintenance therapy for multiple myeloma after autologous transplantation: where do we stand?

Bone marrow transplantation·2015
Same author

Hyperferritinemia and markers of inflammation and oxidative stress in the cord blood of HIV-exposed, uninfected (HEU) infants.

HIV medicine·2015
Same author

Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders.

Bone marrow transplantation·2014

Area of Science:

  • Neonatal care
  • Pediatric psychology
  • Infant health

Background:

  • Neonatal jaundice treatments are generally safe and effective.
  • The potential for vulnerable child syndrome (VCS) following treatment is not well-understood.
  • VCS symptoms can persist for up to six months post-treatment.

Purpose of the Study:

  • To investigate the association between neonatal jaundice treatments and VCS symptoms.
  • To compare maternal perceptions and infant outcomes at six months between jaundiced and non-jaundiced infants.

Main Methods:

  • Survey of mothers of healthy infants with and without jaundice at Yale-New Haven Hospital.
  • Comparison of feeding difficulties, maternal caregiving behaviors, and perceived health problems at six months post-discharge.

Related Experiment Videos

Main Results:

  • Infants with jaundice showed significantly more feeding difficulties and were less likely to be breast-fed at six months.
  • Mothers of jaundiced infants were more likely to leave their infants with others and perceived infant health problems as more serious, seeking emergency care more often.
  • While non-jaundiced infants' mothers reported similar health issues, jaundiced infants' mothers exhibited heightened concern and perceived seriousness.

Conclusions:

  • Neonatal jaundice treatment may be linked to vulnerable child syndrome symptoms.
  • The benefits of treating neonatal jaundice should be weighed against potential risks like VCS.
  • Further research is needed to fully understand and mitigate VCS risks in treated infants.